valsartan has been researched along with Neovascularization, Optic Disc in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fletcher, EL; Hatzopoulos, KM; Vessey, KA; Wilkinson-Berka, JL | 1 |
Binger, KJ; Deliyanti, D; Miller, AG; Samson, AL; Tan, G; Wilkinson-Berka, JL | 1 |
2 other study(ies) available for valsartan and Neovascularization, Optic Disc
Article | Year |
---|---|
The vasoneuronal effects of AT1 receptor blockade in a rat model of retinopathy of prematurity.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Disease Models, Animal; Electroretinography; Female; Fluorescent Antibody Technique, Indirect; Microglia; Microscopy, Confocal; Oxygen; Photic Stimulation; Photoreceptor Cells, Vertebrate; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Tetrazoles; Valine; Valsartan | 2014 |
Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Cytochrome P-450 CYP11B2; Disease Models, Animal; Drug Therapy, Combination; Fadrozole; Follow-Up Studies; Microglia; Oxygen; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Retinal Neovascularization; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2012 |